TROX vs AVTX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TROX · Tronox$2.51 ▼ 3.83%
AVTX · Avalo Therapeutics$6.93 ▲ 4.52%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TROX -29.0%
- AVTX -54.5%
Head to head
| Metric | TROX | AVTX |
|---|---|---|
| Price | $2.51 | $6.93 |
| Change today | ▼ 3.83% | ▲ 4.52% |
| Market cap | $400.86M | $400.71M |
| Return, 3 months | -59.6% | -64.9% |
| Return, year to date | -38.5% | -61.8% |
| Return, 1 year | -24.0% | -54.0% |
| P/E (TTM) | -0.8 | -3.1 |
| P/B | 0.4 | 0.9 |
| P/E percentile vs own 5y | 65th | 17th |
| Dividend yield | 7.97% | – |
| Revenue growth (YoY, latest qtr) | +18.7% | – |
| Net profit growth (YoY) | -103.5% | -75.1% |
| Gross margin | 6.2% | – |
| Operating margin | -3.2% | -154,847.5% |
| Net margin | -18.0% | -170,055.9% |
| Return on equity | -39.1% | -36.3% |
| Analyst target vs. price | +127.1% | +316.0% |
| Analyst buy share | 20% | 71% |
| RSI (14) | 23 | 25 |
| 30-day volatility | 98.9% | 154.5% |
| Max drawdown, 1 year | -75.7% | -71.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TROX is the largest of the group by market value.
- TROX has returned the most over the past year.
- AVTX carries the lowest trailing P/E.
- TROX keeps the most profit per dollar of sales.
- TROX has been the calmest stock over the last 30 days.